AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

Infectious disease at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

14 organizations at AMP 2026 present work in infectious disease. Between them they bring 62 presentations to the program. Most represented: University of Washington (8 on the program), Stanford University (6 on the program), St. Jude Children's Research Hospital (5 on the program). 14 of them have their own page in this guide. As of Nov 12, 2026.

All 321 organizations at AMP 2026 →

Format
Top represented
Showing 1–6 of 14 organizations
OrganizationAMP 2026 Attendance
Med centres
Public research university in Seattle with a genome sciences department and clinical laboratories in genetics and laboratory medicine.
Workshop
Wed, Nov 11
2:00pm–3:50pm
Evaluation of the BioCode® STI + Resistance Panel for STI Detection, Antimicrobial Resistance Markers, and Multiplex STI Panels Reimbursement Considerations
Performance of a multiplex panel detecting chlamydia, gonorrhea, mycoplasma and trichomonas with resistance markers, plus reimbursement.
Workshop hosted by Applied BioCode
Session
Thu, Nov 12
10:15am–11:45am
Clinically Actionable Mutational Signatures in Solid Tumors
Informatics · Solid Tumors
  1. 10:15am–10:45amDetecting Homologous Recombination Deficiency with Genomic and AI-Based ApproachesUniversity of California San Diego
  2. 10:45am–11:15amClinical Utility of Detecting Mismatch Repair Deficiency as a Mutational SignatureBrigham and Women's Hospital
  3. 11:15am–11:45amNovel Mutational Signatures in CancerUniversity of California San Francisco
Talk
Thu, Nov 12
2:30pm–3:00pm
AMP Clinical Validation of cfDNA and ctDNA Assays Working Group
Setting validation standards for liquid biopsy assays in oncology, with attendee input shaping the guideline under development.
Talk
Fri, Nov 13
1:15pm–2:45pm
Beyond Git: Bringing CI/CD to Clinical Bioinformatics
How Git version control and CI/CD pipelines make clinical bioinformatics software reproducible, traceable and ready for regulatory review.
Informatics
Talk
Sat, Nov 14
2:30pm–3:15pm
Beyond the Swab: The Evolution of STI Diagnostics
Sexually transmitted infection testing from culture-era methods to multiplex and point-of-care molecular assays, and what comes next.
Infectious Diseases
Med centres
Private research university in California whose medical school runs clinical genomics, molecular pathology and metagenomic sequencing laboratories.
Session
Thu, Nov 12
10:15am–11:45am
Clinically Actionable Mutational Signatures in Solid Tumors
Informatics · Solid Tumors
  1. 10:15am–10:45amDetecting Homologous Recombination Deficiency with Genomic and AI-Based ApproachesUniversity of California San Diego
  2. 10:45am–11:15amClinical Utility of Detecting Mismatch Repair Deficiency as a Mutational SignatureBrigham and Women's Hospital
  3. 11:15am–11:45amNovel Mutational Signatures in CancerUniversity of California San Francisco
Session
Thu, Nov 12
10:15am–11:45am
Computational Analysis of Fragmentation and Methylation Patterns in ctDNA for Early Cancer Detection
Informatics · Technical Topics
  1. 10:15am–11:00amBespoke Cell-free DNA Fragmentation Biomarkers for Early Cancer DetectionSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
  2. 11:00am–11:45amMulti-Omic Single Molecule Profiling of Cell Free DNA Reveals Cancer SignaturesStanford Univeristy
Talk
Thu, Nov 12
11:00am–11:45am
Multi-Omic Single Molecule Profiling of Cell Free DNA Reveals Cancer Signatures
Single-molecule reads of scant cell-free DNA capture methylation, hydroxymethylation and fragmentation to profile cancers and spot brain metastases.
Informatics · Technical Topics
Session
Fri, Nov 13
8:15am–9:15am
Informatics Plenary Session
Informatics
  1. 8:15am–9:15amTransforming Healthcare Using Deep Data and Remote MonitoringStanford University School of Medicine
Session
Sat, Nov 14
10:15am–11:45am
Foundation Models in Molecular
Informatics
  1. 10:15am–11:00amFrom AI Promise to Clinical Practice: Which Genomic Foundation Models Can You Trust in Molecular Testing?The University of Texas MD Anderson Cancer Center
  2. 11:00am–11:45amScoring Variants with Genomic Foundation ModelsGenomics England
Session
Sat, Nov 14
1:45pm–2:15pm
AMP Electronic Health Record (EHR) Interoperability for Clinical Genomics Data Working Group
A working-group update on making genomic variant data interoperable in electronic health records, and where standards still fall short.
Talk
Sat, Nov 14
2:45pm–4:00pm
Toward a Paradigm Shift in Personalized Therapies for Lymphoma Using Liquid Biopsies
Circulating tumor DNA in diffuse large B-cell lymphoma for genotyping, early response measurement and residual-disease-guided treatment.
Hematopathology · Technical Topics
Pediatric
Paediatric research hospital in Memphis treating childhood cancer and running clinical genome sequencing and transplant virus testing.
Workshop
Wed, Nov 11
11:00am–11:50am
NAT2 Pharmacogenomics: Applying CPIC Guidelines with CDC GeT-RM Reference Materials
NAT2 acetylator genotyping: applying dosing guidelines and using CDC reference materials to validate the assay.
Workshop hosted by Agena Bioscience
Workshop
Wed, Nov 11
1:00pm–1:50pm
Strategies for Optimizing Nucleic Acid Extraction in Molecular Oncology Workflows: Liquid Biopsy, FFPE, and Beyond
Magnetic bead extraction tuned for high-throughput oncology workflows, covering FFPE tissue and cell-free DNA from plasma.
Workshop hosted by Revvity
Talk
Fri, Nov 13
11:00am–11:45am
Molecular Diagnosis and Surveillance of Bone Marrow Failure and Pediatric MDS:
Germline and somatic testing in young patients with marrow failure and MDS risk, including somatic genetic rescue and surveillance choices.
Hematopathology · Solid Tumors
Talk
Fri, Nov 13
1:15pm–2:45pm
Architecting High-Throughput Clinical Genomics: Infrastructure, Trade-offs, and Impact
Infrastructure and software choices behind running whole-genome, exome, RNA and panel testing at pediatric-hospital scale.
Informatics
Talk
Sat, Nov 14
10:15am–11:00am
Progress and Challenges in Standardization of Quantitative Transplant Virus Testing
Why CMV, EBV, BK and adenovirus viral load results still differ between labs, and what harmonisation would take.
Infectious Diseases
Med centres
Public research university and academic medical centre in Birmingham with clinical molecular pathology and next-generation sequencing laboratories.
Talk
Sat, Nov 14
3:15pm–4:00pm
Beyond the Swab: The Evolution of STI Diagnostics
Sexually transmitted infection testing: choosing between lab-based, point-of-care and over-the-counter options for a given population.
Infectious Diseases
Med centres
Medical school and clinical practice of Cornell University in New York, with molecular pathology and computational genomics programmes.
Workshop
Thu, Nov 12
12:00pm–12:30pm
AMP Practice Guidelines Meet the Authors Series: Lung Guideline Update
New lung cancer molecular testing recommendations from the updated joint practice guideline, with the evidence and process behind them.
Session
Fri, Nov 13
1:15pm–2:45pm
Session
Fri, Nov 13
8:15am–9:15am
Informatics Plenary Session
Informatics
  1. 8:15am–9:15amTransforming Healthcare Using Deep Data and Remote MonitoringStanford University School of Medicine
Talk
Sat, Nov 14
1:15pm–1:45pm
AMP Best Practice Guidance for Artificial Intelligence (AI) and Machine Learning (ML) for Molecular Diagnostics Part 1 Working Group
Best practices for validating and deploying AI models in clinical molecular workflows, and how they differ from older machine learning.
Session
Sat, Nov 14
2:30pm–4:00pm
Advances in STI Testing Through the Years
Infectious Diseases
  1. 2:30pm–3:15pmBeyond the Swab: The Evolution of STI DiagnosticsUniversity of Washington
  2. 3:15pm–4:00pmBeyond the Swab: The Evolution of STI DiagnosticsUniversity of Alabama at Birmingham
Session
Sat, Nov 14
7:00am–8:00am
Cleveland Clinic
Cleveland, OH
Med centres
Academic medical center and health system with clinical microbiology and molecular pathology laboratories.
Workshop
Fri, Nov 13
12:40pm–1:10pm
Talk
Sat, Nov 14
11:00am–11:45am
The If, When, and How of Antiviral Resistance Testing for the Immunocompromised Host
Antiviral resistance testing for herpes, cytomegalovirus and HIV in immunocompromised patients, comparing phenotypic and genotypic methods.
Infectious Diseases
Session
Sat, Nov 14
2:30pm–4:00pm
Advances in STI Testing Through the Years
Infectious Diseases
  1. 2:30pm–3:15pmBeyond the Swab: The Evolution of STI DiagnosticsUniversity of Washington
  2. 3:15pm–4:00pmBeyond the Swab: The Evolution of STI DiagnosticsUniversity of Alabama at Birmingham
Session
Sat, Nov 14
8:15am–9:15am
Infectious Diseases Plenary Session
Infectious Diseases
  1. 8:15am–9:15amArtificial Intelligence for Antimicrobial Resistance (and Susceptibility!) PredictionsVanderbilt University Medical Center

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in infectious disease

Tell us what you sell and we’ll find the people at organizations working on infectious disease most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse AMP 2026 by

Exhibit hall

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction